Foghorn Therapeutics Inc. financial data

Symbol
FHTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Technology Square, Suite 700, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 464 % -17%
Debt-to-equity -642 % +46.1%
Return On Equity 168 % -46.6%
Return On Assets -31 % -7.38%
Operating Margin -408 % -16.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.6M shares +31.7%
Common Stock, Shares, Outstanding 55.6M shares +31.7%
Entity Public Float 200M USD -40.4%
Common Stock, Value, Issued 6K USD +50%
Weighted Average Number of Shares Outstanding, Basic 62.6M shares +49%
Weighted Average Number of Shares Outstanding, Diluted 62.6M shares +49%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 25.5M USD -21.7%
Research and Development Expense 98.2M USD -13.6%
General and Administrative Expense 29M USD -12.6%
Operating Income (Loss) -104M USD +8.92%
Nonoperating Income (Expense) 14.9M USD +11.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -89.2M USD +11.6%
Income Tax Expense (Benefit) 1.99M USD -11.3%
Net Income (Loss) Attributable to Parent -91.2M USD +11.6%
Earnings Per Share, Basic -1.92 USD/shares +22%
Earnings Per Share, Diluted -1.92 USD/shares +22%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57.7M USD -18%
Assets, Current 271M USD +2.18%
Operating Lease, Right-of-Use Asset 24.1M USD -23.2%
Other Assets, Noncurrent 848K USD -24.9%
Assets 308M USD -1.61%
Accounts Payable, Current 3.45M USD -46.9%
Employee-related Liabilities, Current 3.77M USD -19.6%
Accrued Liabilities, Current 11.2M USD +27.5%
Contract with Customer, Liability, Current 33.4M USD +17.8%
Liabilities, Current 56.8M USD +9.25%
Contract with Customer, Liability, Noncurrent 250M USD -10.9%
Operating Lease, Liability, Noncurrent 30.3M USD -21.7%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 337M USD -9.21%
Accumulated Other Comprehensive Income (Loss), Net of Tax 360K USD
Retained Earnings (Accumulated Deficit) -539M USD -20.4%
Stockholders' Equity Attributable to Parent -28.3M USD +50.7%
Liabilities and Equity 308M USD -1.61%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.3M USD +5.89%
Net Cash Provided by (Used in) Financing Activities 1.17M USD +1044%
Net Cash Provided by (Used in) Investing Activities 27.1M USD -8.17%
Common Stock, Shares Authorized 175M shares 0%
Common Stock, Shares, Issued 55.6M shares +31.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.08M USD +31.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.4M USD -17.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 143M USD +27.8%
Deferred Tax Assets, Gross 154M USD +23.7%
Operating Lease, Liability 45.1M USD -12.5%
Payments to Acquire Property, Plant, and Equipment 101K USD -84.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -89M USD +11.2%
Lessee, Operating Lease, Liability, to be Paid 51.1M USD -17.2%
Operating Lease, Liability, Current 8.77M USD +4.75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.7M USD +1.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.7M USD +7.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.07M USD -31.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.6M USD -0.58%
Deferred Tax Assets, Operating Loss Carryforwards 631K USD -98.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.9M USD -0.5%
Additional Paid in Capital 510M USD +30.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.23M USD -4.22%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 426K USD -76.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%